Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.
about
Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysisSIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma CellsPVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6.Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.Cancer RNA-Seq Nexus: a database of phenotype-specific transcriptome profiling in cancer cellsThe oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains.The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer.Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152.lncRNAs and MYC: An Intricate Relationship.Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.The bright side of dark matter: lncRNAs in cancerKanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells.LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis.Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications.Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer.Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma.LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM).lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis
P2860
Q26748767-02E41371-00F0-44FC-850A-56E89F80ECE9Q27341759-A5B5E7EB-B5C8-450B-8D01-51A76BCD75EBQ28388640-E5541110-DBD5-4ACC-B069-8C5BB17CB621Q33738854-85A5E27D-1AB9-4D41-9A55-AFA952870153Q33755896-34F5AF66-7AF6-4F3E-80C3-431627D43311Q35443085-EAEB3F6D-5D7B-467A-B8E7-BBE658051E64Q35851453-15E8E1AD-AA2B-4046-8647-128C9E8F4294Q35921820-08D3C68D-62FE-437A-AA59-B9D8217D15D9Q36032514-A7207611-40AD-4CBB-A82E-6D6BA6230B76Q36844307-AB4B474A-BAF1-41F5-8FCA-2EA99E25583EQ37448230-4800A535-82AB-49B7-BD49-C56FAD5D066CQ37665189-2F10989B-AD6A-4274-B20D-4665A50A6C34Q38658076-AA883EDD-DB3C-4F86-BC83-B597DE222A1FQ38748263-4C0F61CF-F48A-43B4-9001-D52DAE32FA49Q38915010-5F434384-26B0-4117-9CC6-B3D7D918CD39Q41113421-A5346D33-F094-4D18-83FB-CB1B536E9A95Q42880610-866BAB2A-F5FF-4F7C-88AB-16D92CBD7C2FQ46077218-EA97D72C-060C-45C0-95CE-CCF9D0C958F2Q47899728-26B864D5-8B6D-4271-A77D-9329C84AAD54Q50042107-0794CB3E-77A4-4C28-B243-A4F3F699149AQ50098273-8A47FA32-D420-4F24-837C-6DF6BEE8C002Q52559185-5E4D9032-9D2D-44BA-B2FB-004EEA5354F1Q58773738-FF0F857B-1D23-4986-90B9-6A2642CB32E2
P2860
Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Frequent coamplification and c ...... alignant pleural mesothelioma.
@en
type
label
Frequent coamplification and c ...... alignant pleural mesothelioma.
@en
prefLabel
Frequent coamplification and c ...... alignant pleural mesothelioma.
@en
P2093
P2860
P4510
P1476
Frequent coamplification and c ...... alignant pleural mesothelioma.
@en
P2093
Barbara Mino
David C Rice
Erick Riquelme
Heather Y Lin
Jaime Rodriguez
Milind B Suraokar
P2860
P304
P356
10.1097/JTO.0000000000000202
P577
2014-07-01T00:00:00Z